AI Transparency Report
The New York Blood Center Inc. demonstrates a generally stable financial position, with assets consistently exceeding liabilities across its filing history. In the latest available period (202312), the organization reported assets of $784,292,844 against liabilities of $226,434,295, indicating a healthy balance sheet. Revenue has shown significant growth over the past few years, increasing from $392,002,693 in 202112 to $564,818,942 in 202312, reflecting an expanding operational scale. However, the 202312 filing shows expenses ($599,527,174) exceeding revenue ($564,818,942), resulting in a deficit for that period. This trend of expenses sometimes outpacing revenue is also observed in earlier periods like 201803 and 201703, suggesting a need for careful monitoring of operational efficiency and cost management to ensure long-term sustainability. The organization's NTEE code E610 (Blood Banks) aligns with its mission, and the consistent filing of IRS Form 990s indicates a commitment to regulatory transparency.